Preventive Cognitive Therapy Versus Care as Usual in Cognitive Behavioral Therapy Responders: A Randomized Controlled Trial
De Jonge, M.,
Bockting, C.L.H.,
Kikkert, M.J., van Dijk, M.K., van Schaik, D.J.F.,
Peen, J., Hollon, S.D. &
Dekker, J.J.M.Verschenen in Journal of Consulting and Clinical Psychology, 87 (6), 521–529 (2019)
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use
Ferraro, L., La Cascia, C., Quattrone, D., Sideli, L., Matranga, D., Cappucio, V., WP2 EU-GEI Group,
De Haan, L. & di Forti, M., et al.
Verschenen in Schizophrenia Bulletin, Volume 46, Issue 3, 517–529 (2019)
Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial
Van Emmerik-van Oortmerssen, K.,
Blankers, M., Vedel, E., Kramer, F.,
Goudriaan, A.E., van den Brink, W. & Schoevers, R.A.
Verschenen in Addictive Behaviors, Volume 103, April 2020, 106228 (2019)
Measuring process indicators and adverse events to assess the quality of care for inpatients with psychosis
Vermeulen, J.M., van Rooijen, G., van Tricht, M.J., van Dijk, M. &
De Haan, L.Verschenen in Journal of Mental Health, Volume 30, Issue 5, 564-570 (2019)
Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling
van Rooijen, G., van Rooijen, M., Maat, A., Vermeulen, J.M., Meijer, C.J., Ruhé, H.G.,
De Haan, L. & GROUP Investigators
Verschenen in Schizophrenia Researh, 208, 82-89 (2019)
Linking childhood emotional abuse and depressive symptoms: The role of emotion dysregulation and interpersonal problems
Christ, C.,
De Waal, M.M.,
Dekker, J.J.M., van Kuijk, I., van Schaik, D.J.F.,
Kikkert, M.J.,
Goudriaan, A.E.,
Beekman, A.T.F. &
Dekker, J.J.M.Verschenen in Plos One, 14 (2), 1-18 (2019)
Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial
Van Emmerik-van Oortmerssen, K.,
Vedel, E., Kramer, F.,
Blankers, M.,
Dekker, J.J.M., van den Brink, W. & Schoevers, R.A.
Verschenen in Drug and Alcohol Dependence, 197 (2) (2019)
Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis
Malda, A., Boonstra, N., Barf, H., de Jong, S., Aleman, A., Addington, J.,
De Haan, L., Pijnenborg, G.H.M. & et al.
Verschenen in Frontiers in Psychiatry, 10, 345 (2019)
Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis
Cakici, N., Bot, M., Lamers, F., Janssen, T., van der Spek, P.J.,
De Haan, L., Bahn, S., Penninx, B.W.J.H. & van Beveren, N.J.M.
Verschenen in European Neuropsychopharmacology, Volume 29, Issue 7, 835-846 (2019)
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning – Results from the EU-GEI study
Menghini-Müller, S., Studerus, E., Ittig, S., Heitz, U., Egloff, L., Andreou, C., Valmaggia, L.R., Kempton, M.J., van der Gaag, M.,
De Haan, L. & et al.
Verschenen in European Psychiatry, 59, 52-59 (2019)
Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
Guloksuz, S., Pries, L.K., Delespaul, P., Kenis, G., Luykx, J.J., Lin, B.D.,
De Haan, L., GROUP Researchers & van Os, J.
Verschenen in World Psychiatry, 18(2), 173-182 (2019)
Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects
Mackey, S., Allgaier, N., Chaarani, B., Spechler, P., Orr, C., Bunn, J., Allen, N.B.,
Goudriaan, A.E. & et al.
Verschenen in The American Journal of Psychiatry, Volume 176, Issue 2, February 01, 2019, 119-128 (2019)
Practical Significance of Longitudinal Measurement Invariance Violations in the Dutch-Flemish PROMIS Item Banks for Depression and Anxiety: An Illustration With Ordered-Categorical Data
Flens, G., Smits, N., Terwee, C.B., Pijck, L., Spinhoven, P. &
De Beurs, E.Verschenen in Assassment, Volume 28, Issue 1, 277-294 (2019)
Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients
van der Pluijm, M., Sutterland, A.L., van Kullenbrog, A.B.P., Zoetekouw, L.,
De Haan, L., Booij, J. & van de Giessen, E.
Verschenen in Therapeutic Advances in Psychopharmacology, 9, 1-7 (2019)
Patient Characteristics Predicting Abstinence in Substance Use Disorder Patients With Comorbid Mental Disorders
van Hagen, L.J.,
De Waal, M.M.,
Christ, C.,
Dekker, J.J.M. &
Goudriaan, A.E.Verschenen in Journal of Dual Diagnosis , Volume 15, Issue 4, 312-323 (2019)
Obsessive-compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels
Schirmbeck, F., Konijn, M., Hoetjes, V., Zink, M. &
De Haan, L.Verschenen in European Archives of Psychiatry and Clinical Neuroscience, 269, 245-255 (2019)
Meta‐analysis on the efficacy of psychological treatments for anorexia nervosa
Van den Berg, E.M., Houtzager, L., de Vos, J., Daemen, I., Katsaragaki, G., Karyotaki, E., Cuijpers, P. &
Dekker, J.J.M.Verschenen in European Eating Disorders Review, Volume 27, issue 4, 331-351 (2019)
Mentalization-Based Treatment Versus Specialist Treatment as Usual for Borderline Personality Disorder: Economic Evaluation Alongside a Randomized Controlled Trial With 36-Month Follow-Up
Blankers, M.,
Koppers, D., Laurenssen, M.P.,
Peen, J., Smits, M.L., Luyten, P., Busschbach, J., Kamphuis, J.H. &
Kikkert, M.J.Verschenen in Journal of Personality Disorders, 35 (no. 3), 373-392 (2019)
Mental disorders and the risk of adult violent and psychological victimisation: a prospective, population-based study
Christ, C., ten Have, M., de Graaf, R., van Schaik, D.J.F.,
Kikkert, M.J.,
Dekker, J.J.M. &
Beekman, A.T.F.Verschenen in Epidemiology and Psychiatric Sciences, Volume 29, e13, 1-10 (2019)
